Basic Information
Basic information for SOX2-OT-275-23aa-1
Peptide Name SOX2-OT-275-23aa-1
Genome Position chr3:181175561-181175583,181563720-181563765[+]
Species Human
Peptide Sequence MAYTSEKYHYFLHWTARYFCLEK
Peptide Length 23
Unique No (SOX2-OT-201-23aa,SOX2-OT-204-23aa-1,SOX2-OT-214-23aa,SOX2-OT-215-23aa,SOX2-OT-226-23aa-2,SOX2-OT-241-23aa,SOX2-OT-256-23aa,SOX2-OT-273-23aa,SOX2-OT-282-23aa,SOX2-OT-285-23aa,SOX2-OT-286-23aa,SOX2-OT-289-23aa,SOX2-OT-293-23aa,SOX2-OT-295-23aa,SOX2-OT-299-23aa,SOX2-OT-300-23aa,SOX2-OT-303-23aa,SOX2-OT-304-23aa)
Grand Average of Hydropathicity -0.5565
Relative Molecular Mass 3384.82
Experimental Evidences 2:lncORF,ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000645423;SOX2-OT-275
Transcript Length 1583
Coding Ability 0.3696
DNA Sequence Corresponding to Peptide ATGGCATACACATCTGAAAAATACCACTACTTCCTTCATTGGACTGCAAGGTATTTCTGTTTGGAAAAG
Experimental Evidences
   lncORF
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :